Investor Relations

Stallergenes Greer in Brief

Stallergenes Greer, a worldwide allergy company

Welcome to Stallergenes Greer. Two companies united in one fully integrated global biopharmaceutical company. Ready to make allergy history.
We are passionate about everything we do and every human that our work touches. Our progressive science is focused completely on improving the lives of people with allergies.

Stallergenes Greer Results

 

2017 Annual Report
Press release

November 14, 2018

Stallergenes Greer Announces U.S. FDA Approval of Pediatric Indication Extension for OralairĀ® Sublingual Immunotherapy Tablet for the Treatment of Grass Pollen Allergy

All press releases